000 | 01525 a2200409 4500 | ||
---|---|---|---|
005 | 20250516151419.0 | ||
264 | 0 | _c20140116 | |
008 | 201401s 0 0 eng d | ||
022 | _a1365-4632 | ||
024 | 7 |
_a10.1111/ijd.12017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Lucinda S | |
245 | 0 | 0 |
_aMolecularly targeted therapies for nonmelanoma skin cancers. _h[electronic resource] |
260 |
_bInternational journal of dermatology _cJun 2013 |
||
300 |
_a654-65 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnilides _xtherapeutic use |
650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBenzamides _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Basal Cell _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
650 | 0 | 4 | _aCetuximab |
650 | 0 | 4 |
_aDermatofibrosarcoma _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
650 | 0 | 4 |
_aPyridines _xtherapeutic use |
650 | 0 | 4 |
_aPyrimidines _xtherapeutic use |
650 | 0 | 4 |
_aSarcoma, Kaposi _xdrug therapy |
650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
700 | 1 | _aColegio, Oscar R | |
773 | 0 |
_tInternational journal of dermatology _gvol. 52 _gno. 6 _gp. 654-65 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ijd.12017 _zAvailable from publisher's website |
999 |
_c22756856 _d22756856 |